In a different approach, Lee et al. demonstrated that a protein called Znf179 is involved in reprogramming GBM cells into a more differentiated phenotype by inducing cell arrest in the G0/G1 phase through p53-p21-p27 cell cycle signalling pathways. The gene discussed is RNF112; the disease is glioblastoma.